A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis
for Secondary AML
Sites in Duarte, San Diego & Sacramento
Sponsor: Aspera Biomedicines, Inc.
Sex: All·Age: 18+
Code: NCT07250646·Phase 1·Recruiting·Listed Nov 2025